Management of airway hemangiomas

Expert Review of Respiratory Medicine

Volumn 4, Issue 4, 2010, Pages 455-462

  Balakrishnan, Karthik ^a   Perkins, Jonathan A ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

airway; endoscopy; hemangioma; laser; propranolol; steroid; stridor; surgery; treatment

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; BEVACIZUMAB; CORTICOSTEROID; PROPRANOLOL; VINCRISTINE;

AIRWAY; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CUSHING SYNDROME; DIGESTIVE SYSTEM ULCER; ENDOSCOPY; GASTROINTESTINAL DISEASE; GROWTH RETARDATION; HEMANGIOMA; HUMAN; HYPERTENSION; HYPOGLYCEMIA; LASER SURGERY; LETHARGY; LIVER HEMANGIOMA; NEUROLOGIC DISEASE; PNEUMONIA; PREDICTION; REFLUX ESOPHAGITIS; RETINA DISEASE; REVIEW; STANDARDIZATION;

EID: 77955029017     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.10.46     Document Type: Review

References (39)

1. MacArthur CJ. Head and neck hemangiomas of infancy. Curr. Opin. Otolaryngol. Head Neck Surg. 14(6), 397-405 (2006).
2. Haggstrom AN, Drolet BA, Baselga E et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 118(3), 882-887 (2006).
3. Smith DS, Lee KK, Milczuk HA. Otolaryngologic manifestations of PHACE syndrome. Int. J. Pediatr. Otorhinolaryngol. 68(11), 1445-1450 (2004).
4. O-Lee TJ, Messner A. Subglottic hemangioma. Otolaryngol. Clin. North Am. 41(5), 903-911 (2008).
5. Perkins JA, Oliaei S, Garrison MM, Manning SC, Christakis DA. Airway procedures and hemangiomas: treatment patterns and outcome in U.S. pediatric hospitals. Int. J. Pediatr. Otorhinolaryngol. 73(9), 1302-1307 (2009).
6. Badi AN, Kerschner JE, North PE, Drolet BA, Perkins JA. Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Int. J. Pediatr. Otorhinolaryngol. 73(9), 1187-1191 (2009).
7. O TM, Alexander RE, Lando T et al. Segmental hemangiomas of the upper airway. Laryngoscope 119(11), 2242-2247 (2009).
8. Perkins JA, Duke W, Chen EY, Manning SC. Emerging concepts in airway infantile hemangioma assessment and management. Otolaryngol. Head Neck Surg. 141(2), 207-212 (2009).
9. Perkins JA, Chen EY, Hoffer FA, Manning SC. Proposal for staging airway hemangiomas. Otolaryngol. Head Neck Surg. 141(4), 516-521 (2009).
10. Ohlms LA, Jones DT, McGill TJ, Healy GB. Interferon alfa-2a therapy for airway hemangiomas. Ann. Otol. Rhinol. Laryngol. 103(1), 1-8 (1994).
11. MacArthur CJ, Senders CW, Katz J. The use of interferon alfa-2a for life-threatening hemangiomas. Arch. Otolaryngol. Head Neck Surg. 121(6), 690-693 (1995)
12. Soumekh B, Adams GL, Shapiro RS. Treatment of head and neck hemangiomas with recombinant interferon a 2B. Ann. Otol. Rhinol. Laryngol. 105(3), 201-206 (1996).
13. Enjolras O, Breviere G, Roger G et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch. Pediatr. 11(2), 99-107 (2004).
14. Saetti R, Silvestrini M, Cutrone C, Narne S. Treatment of congenital subglottic hemangiomas: our experience compared with reports in the literature. Arch. Otolaryngol. Head Neck Surg. 134(8), 848-851 (2008).
15. Rahbar R, Nicollas R, Roger G et al. The biology and management of subglottic hemangioma: past, present, future. Laryngoscope 114(11), 1880-1891 (2004).
16. Bitar MA, Moukarbel RV, Zalzal GH. Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol. Head Neck Surg. 132(2), 226-231 (2005).
17. Pransky SM, Canto C. Management of subglottic hemangioma. Curr. Opin. Otolaryngol. Head Neck Surg. 12(6), 509-512 (2004).
18. Ho K-HK, Ulualp SO. Laser-assisted management of congenital and acquired pediatric airway disorders: case reports and review of the literature. Photomed. Laser Surg. 26(6), 601-607 (2008).
19. Angiero F, Benedicenti S, Benedicenti A, Arcieri K, Berne E. Head and neck hemangiomas in pediatric patients-treated with endolesional 980-nm diode laser. Photomed. Laser Surg. 27(4), 553-559 (2009).
20. Nicolai T, Fischer-Truestedt C, Reiter K, Grantzow R. Subglottic hemangioma: a comparison of CO2 laser, Neodym-Yag laser, and tracheostomy. Pediatr. Pulmonol. 39(3), 233-237 (2005).
21. Naiman AN, Ayari S, Froehlich P. Controlled risk of stenosis after surgical excision of laryngeal hemangioma. Arch. Otolaryngol. Head Neck Surg. 129(12), 1291-1295 (2003).
22. Bajaj Y, Hartley BEJ, Wyatt ME, Albert DM, Bailey CM. Subglottic haemangioma in children: experience with open surgical excision. J. Laryngol. Otol. 120(12), 1033-1037 (2006).
23. Vijayasekaran S, White DR, Hartley BEJ et al. Open excision of subglottic hemangiomas to avoid tracheostomy. Arch. Otolaryngol. Head Neck Surg. 132(2), 159-163 (2006).
24. Leaute-Labreze C, de la Roque ED, Hubiche T et al. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med. 358(24), 2649-2651 (2008).
25. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 120(4), 676-681 (2010).
26. Jephson CG, Manunza F, Syed S et al. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int. J. Pediatr. Otorhinolaryngol. 73(12), 1821-1823 (2009).
27. Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int. J. Pediatr. Otorhinolaryngol. 74(3), 323-325 (2010).
28. Denoyelle F, Leboulanger N, Enjolras O et al. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int. J. Pediatr. Otorhinolaryngol. 73(8), 1168-1172 (2009).
29. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J. Pediatr. 156(2), 335-338 (2010).
30. Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr. Opin. Otolaryngol. Head Neck Surg. 17(6), 458-459 (2009).
31. Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. Int. J. Pediatr. Otorhinolaryngol. 74(4), 338-342 (2010).
32. Boye E, Jinnin M, Olsen BR. Infantile hemangioma: challenges, new insights, and therapeutic promise. J. Craniofac. Surg. 20(SUPPL. 1), 678-684 (2009).
33. Mahajan D, Miller C, Hirose K, McCullough A, Yerian L. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J. Hepatol 49(5), 867-870 (2008).
34. Ach T, Thiemeyer D, Hoeh AE, Schaal KB, Dithmar S. Intravitreal bevacizumab for retinal capillary haemangioma: longterm results. Acta Ophthalmol. 88(4), e137-e138 (2010).
35. Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N. Engl. J. Med. 362(11), 1005-1013 (2010).
36. Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis 12(2), 197-207 (2009).
37. Xiao X, Liu J, Sheng M. Synergistic effect of estrogen and VEGF on the proliferation of hemangioma vascular endothelial cells. J. Pediatr. Surg. 39(7), 1107-1110 (2004).
38. Khan ZA, Boscolo E, Picard A et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J. Clin. Invest. 118(7), 2592-2599 (2008).
39. Inglis AF Jr, Perkins JA, Manning SC, Mouzakes J. Endoscopic posterior cricoid split and rib grafting in 10 children. Laryngoscope 113(11), 2004-2009 (2003).